% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

  • cameroninbaghdad cameroninbaghdad Apr 13, 2013 4:07 PM Flag

    Biggest scam in biotech

    Biotech companies are expected to incur big losses through R&D and other expenses but once they bring their drug to market investors expect to see profits, or at least declining losses. That is not the case with IRWD. Analyst estimate 64 cents a share loss this quarter, almost double the loss from last year Q1. Furthermore, click on Analyst Estimates for this drug on the yahoo summary page. It's a sea of RED. This years estimate is at $-2.21 a share and next year is around $-1.35. IRWD has a lot of cash on hand, gathering some extra $175 million this past January from an awful financing deal which carries an 11% interest rate. If analyst estimates hold up they will have burned through all their precious cash sometime by the middle of next year. They surely will not wait to raise more cash by then. Expect a secondary offering to come by end of this year or early next year. This is the most bloated biotech in the entire sector. If the market takes a turn this stock will be one of the hardest hit. For this quarters estimate, revenues are expected anywhere from as high as $8+ million to as low as $800k. I am expecting somewhere between $1.5 to 2 million, if they are lucky. Time will soon tell...

15.88+0.48(+3.12%)Sep 30 4:00 PMEDT